Discovery and development of the BHAP nonnucleoside reverse transcriptase inhibitor delavirdine mesylate

Pharm Biotechnol. 1998:11:285-312. doi: 10.1007/0-306-47384-4_13.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-HIV Agents / chemical synthesis*
  • Anti-HIV Agents / metabolism
  • Delavirdine / chemical synthesis*
  • Delavirdine / metabolism
  • Delavirdine / therapeutic use
  • Drug Design
  • Humans
  • Reverse Transcriptase Inhibitors / chemical synthesis*
  • Reverse Transcriptase Inhibitors / metabolism

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Delavirdine